Regeneron Pharmaceuticals (REGN) Stock Price Target 2026

The average analyst price target for Regeneron Pharmaceuticals is $887.26, 1.4% below the current price. Of 23 analysts, 17 rate it Buy and 6 Hold. Targets range from $185 to $1,175. The latest change came on Nov 2, 2026, when Leerink Partners raised its price target on Regeneron Pharmaceuticals from $835 to $997 and kept a Market Perform rating.